Work

12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis (P11-1.003)

Year: 2023

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000201896

Authors: Vicente Villanueva, Wendyl D’Souza, Edward Faught, Pavel Klein, Markus Reuber, Felix Rosenow, Javier Salas-Puig, Victor Soto Insuga, Adam Strzelczyk, Jerzy P. Szaflarski, Herve Besson, Tony Daniels, Florin Floricel, Cedric Laloyaux, Veronica Sendersky, Sophia Zhou, Bernhard J. Steinhoff

Institutions: Hospital Universitari i Politècnic La Fe, The University of Melbourne, St Vincent's Hospital Melbourne, Mid Atlantic Epilepsy and Sleep Center, University of Sheffield, Vall d'Hebron Hospital Universitari, Hospital Infantil Universitario Niño Jesús, University of Alabama at Birmingham, UAB Medicine, UCB Pharma (Netherlands), UCB Pharma (United States), UCB Pharma (Germany), UCB Pharma (Belgium), University of Freiburg

Language: English

Topic: Epilepsy research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367305487

FWCI:

Cites:

Cited by:

Related to: 10